The breakthrough diabetes drug Ozempic may lower the risk of opioid overdoses in certain patients, according to a new study published Wednesday, signaling that the wonder drug may eventually be used as an alternative form of treatment for opioid use disorder.

Semaglutide, the active ingredient in Ozempic and the weight loss drug Wegovy, was associated with “significantly lower” opioid overdose risk than other similar medications for patients diagnosed with both Type 2 diabetes and opioid use disorder.